Implant for targeting therapeutic procedure
US-11337772-B2 · May 24, 2022 · US
US11529211B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11529211-B2 |
| Application number | US-201916661663-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 23, 2019 |
| Priority date | Apr 26, 2012 |
| Publication date | Dec 20, 2022 |
| Grant date | Dec 20, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An implantable tissue marker device is provided to be placed in a soft tissue site through a surgical incision. The device can include a bioabsorbable body in the form of a spiral and defining a spheroid shape for the device, the spiral having a longitudinal axis, and turns of the spiral being spaced apart from each other in a direction along the longitudinal axis. A plurality of markers can be disposed on the body, the markers being visualizable by a radiographic imaging device. The turns of the spiral are sufficiently spaced apart to form gaps that allow soft tissue to infiltrate between the turns and to allow flexibility in the device along the longitudinal axis in the manner of a spring.
Opening claim text (preview).
The invention claimed is: 1. A bioabsorbable surgical implant sized for placement within a surgically created cavity, the implant comprising: a bioabsorbable body including a continuous framework element, the framework element forming a spiral extending between a first end portion and a second end portion and having an open center, wherein the first end portion includes a first extension and the second end portion includes a second extension, wherein the first and second extensions each extend into and terminate within the open center of the body. 2. The implant of claim 1 , wherein the first and second extensions are coaxial with a longitudinal axis of the body. 3. The implant of claim 1 , wherein the first extension extends orthogonally from the framework element at the first end portion and the second extension extends orthogonally from the framework element at the second end portion. 4. The implant of claim 1 , wherein the body includes a plurality of radio-opaque markers secured to the framework element in a spaced configuration. 5. The implant of claim 4 , wherein the plurality of radio-opaque markers are spaced around the spiral of the framework element to outline a border of the surgically created cavity after placement of the implant into the surgically created cavity and upon imaging of the implant. 6. The implant of claim 4 , wherein the spaced configuration of the plurality of radio-opaque markers is such that in a two-dimensional projection of the implant, each radio-opaque marker from the plurality of radio-opaque markers does not overlap any other radio-opaque marker on the framework element. 7. The implant of claim 4 , wherein each of the radio-opaque markers from the plurality of radio-opaque markers is spaced at least 0.6 cm from each of the other radio-opaque markers. 8. The implant of claim 4 , wherein each of the radio-opaque markers from the plurality of radio-opaque markers is between 0.6 cm and 5.0 cm from each of the other radio-opaque markers. 9. The implant of claim 1 , wherein the spiral of the framework element includes a plurality of turns spaced apart from one another in a direction along a longitudinal axis of the body to allow tissue or a suture to pass across a peripheral boundary of the body and into the open center of the body. 10. The implant of claim 1 , wherein the framework element is arranged and configured with sufficient rigidity to maintain the spiral before, during, and after placement into the surgically created cavity. 11. The implant of claim 1 , wherein the spiral formed by the framework element has a diameter between about 2 cm to about 6 cm. 12. The implant of claim 1 , wherein the spiral formed by the framework element has a spring constant in a direction of a longitudinal axis of the spiral of between 5 and 70 grams per millimeter. 13. The implant of claim 1 , wherein the first extension includes a first radio-opaque marker and the second extension includes a second radio-opaque marker. 14. The implant of claim 13 , wherein the first and second extensions each include a pocket or an opening, the first and second radio-opaque markers being disposed in the pocket or the opening, respectively. 15. The implant of claim 14 , wherein the first and second radio-opaque markers disposed within the pocket or the opening in the first and second extensions at the first and second end portions, respectively, have a different shape from a plurality of radio-opaque markers spaced about the spiral of the framework element. 16. The implant of claim 1 , wherein the surgically created cavity is a lumpectomy cavity. 17. The implant of claim 1 , wherein the body is constructed of a polymer that is at least one of extruded or injection molded. 18. The implant of claim 1 , wherein the body further comprises a plurality of suture portions configured to receive at least one suture to maintain a position of the implant relative to walls of the surgically created cavity. 19. The implant of claim 1 , wherein the body is arranged and configured to flex. 20. The implant of claim 1 , further comprising a strut extending along a longitudinal axis of the body between the first and second extensions, the strut being configured to limit compression of the body. 21. A surgical implant sized for placement within a surgically created lumpectomy cavity, the implant comprising: a spirally-shaped, spheroid body defining an open center and having a longitudinal axis, the spheroid body including: a first polar region including a first extension; a second polar region including a second extension, the first and second extensions being coaxial with and extending toward one another along the longitudinal axis of the spheroid body; and an equatorial region extending between the first and second polar regions; and a plurality of radio-opaque clips distributed around the equatorial region of the spheroid body. 22. The implant of claim 21 , wherein the first and second extensions extend into and terminate within the open center of the spheroid body. 23. The implant of claim 21 , wherein the spheroid body includes gaps configured to allow tissue around the surgically created cavity to infiltrate the body. 24. The implant of claim 21 , wherein the spirally-shaped, spheroid body is integrally formed. 25. The implant of claim 21 , further comprising a first radio-opaque marker located in or on the first extension and a second radio-opaque marker located in or on the second extension. 26. The implant of claim 25 , wherein the plurality of radio-opaque clips have a different shape than the first and second radio-opaque markers. 27. The implant of claim 26 , wherein one or more of the plurality of radio-opaque clips has a D-shape.
Templates · CPC title
Mammary prostheses · CPC title
(bio)absorbable, (bio)resorbable or resorptive · CPC title
magnetic, e.g. NMR or MRI · CPC title
Calibration of imaging systems, e.g. using test probes {, Phantoms; Calibration objects or fiducial markers such as active or passive RF coils surrounding an MR active material} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.